RHOLISTIQ
Dead / Abandoned — Abandoned — no statement of use filed (as of 07 Oct 2024)
What this means for you
This application is over — abandoned 07 Oct 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90095950
- Mark type
- Stylized text
- Filed
- 05 Aug 2020
- Published for opposition
- 06 Jul 2021
- Abandoned
- 07 Oct 2024
- Attorney of record
- Michael J. Leonard
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system; pharmaceutical preparations for the prevention and treatment of inflammatory diseases; pharmaceutical preparations for the prevention and treatment of fibrotic diseases and disorders
Owner
- Kadmon Pharmaceuticals, LLC, Warrendale, PA, US
- Kadmon Pharmaceuticals, LLC, Warrendale, PA, US
Prosecution history
- 07 Oct 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 07 Oct 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 29 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Feb 2024 — SOU EXTENSION 5 GRANTED
- 28 Feb 2024 — SOU EXTENSION 5 FILED
- 28 Feb 2024 — SOU TEAS EXTENSION RECEIVED
- 01 Sept 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Aug 2023 — SOU EXTENSION 4 GRANTED
- 30 Aug 2023 — SOU EXTENSION 4 FILED
- 30 Aug 2023 — SOU TEAS EXTENSION RECEIVED
- 02 Mar 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Feb 2023 — SOU EXTENSION 3 GRANTED
- 28 Feb 2023 — SOU EXTENSION 3 FILED
- 28 Feb 2023 — SOU TEAS EXTENSION RECEIVED
- 26 Aug 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED